The Latest Cardiac and Vascular News
PALO ALTO, Calif., July 2, 2018 /PRNewswire/ — ReCor Medical announced today that the US Food & Drug Administration approved the Company’s new pivotal study of the Paradise Ultrasound Denervation System for the treatment of hypertension: RADIANCE-II. Building upon the recent positive results of the Company’s RADIANCE-HTN SOLO study, RADIANCE-II will be […]
INGELHEIM, Germany & INDIANAPOLIS–(BUSINESS WIRE)–Boehringer Ingelheim and Eli Lilly and Company (NYSE:LLY) announced today that the European Medicines Agency (EMA) Committee for Medicinal Products for Human Use (CHMP) has issued a positive opinion to update the labels of Jardiance® (empagliflozin), Synjardy® (empagliflozin and metformin) and Glyxambi® (empagliflozin and linagliptin) to include additional important […]
EDEN PRAIRIE, Minn., June 29, 2018 /PRNewswire/ — MIVI Neuroscience, Inc. announced today it has successfully achieved first-in-man usage of the DAISe Clot Management System for next generation treatment of ischemic stroke. The proprietary DAISe Clot Management System is uniquely designed to remove clot as well as filter / capture clot emboli that […]
EDEN PRAIRIE, Minn., June 29, 2018 (GLOBE NEWSWIRE) — CHF Solutions, Inc. (NASDAQ:CHFS) today announced the pricing of an underwritten public offering of 2,214,930 shares of its common stock at a price to the public of $2.12 per share, for gross proceeds of approximately $4.7 million prior to deducting underwriting […]
SUWANEE, GA. , June 28, 2018 (GLOBE NEWSWIRE) — SANUWAVE Health, Inc. (OTCQB: SNWV) SANUWAVE is pleased to announce that since receiving clearance from the FDA in late December 2017, its presence has been increasing in the medical device field through attendance at various trade shows around the globe. SANUWAVE’s network of […]
Santa Monica, CA, June 29, 2018 (GLOBE NEWSWIRE) — BioSig Technologies, Inc. (OTCQB: BSGM), a medical technology company developing a proprietary biomedical signal processing platform designed to address an unmet technology need for the $4.6 billion electrophysiology (EP) marketplace, today announced that it will be presenting at the Q2 2018 Emerging Medical […]
Tel Aviv, Israel, June 29, 2018 (GLOBE NEWSWIRE) — InspireMD, Inc. (NYSE American: NSPR), a leader in embolic prevention systems (EPS) / thrombus management technologies and neurovascular devices, today announced the pricing of an underwritten public offering of 33,333,333 units at a price to the public of $0.30 per unit. InspireMD expects […]
CAMBRIDGE, Mass., June, 29, 2018 /PRNewswire/ — The Broad Institute of MIT and Harvard and Bayer are launching the Precision Cardiology Laboratory (PCL), a new endeavor that will pursue scientific insights aimed at developing new therapies for heart failure. According to the American Heart Association, more than 900,000 people are diagnosed with heart failure every […]
CHICAGO, June 29, 2018 /PRNewswire-USNewswire/ — The American Heart Association recently selected Northwestern Medicine as one of six centers to be part of a new, grant-funded national network dedicated to researching and understanding the causes of atrial fibrillation, the most common type of irregular heartbeat. At Northwestern, a $3.7 million grant will fund research specifically on […]
SUNNYVALE, Calif.–(BUSINESS WIRE)–Silk Road Medical, Inc., a company dedicated to preventing the devastating burden of stroke through surgical innovation, today announced the presentation of real-world data for the treatment of patients with carotid artery disease at risk for stroke at the Society for Vascular Surgery 2018 Vascular Annual Meeting (VAM). […]
